Clinical Trial Update: Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chloroquine with VELCADE and cyclophosphamide in relapsed/refractory multiple myeloma; study terminated with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Chloroquine (chloroquine)
• Velcade (bortezomib)

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2015-06-01